|
2025
|
G/S
|
Pharmaceuticals for treatment of genetic diseases and
disorders; pharmaceuticals for treatment o... |
|
2023
|
G/S
|
Pharmaceuticals for treatment of genetic diseases and disorders; pharmaceuticals for treatment of... |
|
2020
|
Invention
|
Stabilized liquid anti-rsv antibody formulations. The present invention provides liquid formulati... |
|
2019
|
G/S
|
Patient support program, namely, providing information about eligibility for financial assistance... |
|
2015
|
Invention
|
Manufacturing method. This application is directed to a method of producing vials containing a co... |
|
|
Invention
|
Antibodies against and methods for producing vaccines for respiratory syncytial virus. The presen... |
|
2007
|
Invention
|
Expression constructs expressing prkag3. Transgenic non-human animals that express the γ3 subunit... |
|
|
Invention
|
Variants of the alpha 1 subunit of human ampk. Variants of the α subunit of AMPK, nucleic acids e... |
|
|
Invention
|
Variants of the gamma chain of ampx, dna sequences encoding the same, and uses thereof. Variants ... |
|
2005
|
Invention
|
Crystals and structure of synagis fab. The present invention provides crystalline forms and three... |
|
|
Invention
|
New method. The invention provides methods of screening test compounds for their ability to reduc... |
|
|
G/S
|
Cosmetics; cosmetic preparations for skin care. Pharmaceutical preparations, not including pharm... |
|
2004
|
Invention
|
Use of heterocyclic compounds as scce inhibitors. The present invention relates to heterocyclic i... |
|
|
Invention
|
Use of fused heterocyclic compounds as scce inhibitors for the treatment of skin conditions or ca... |
|
2003
|
Invention
|
Autoimmune conditions and nadph oxidase defects. The invention relates to methods and materials i... |
|
|
Invention
|
Variants of the α1 subunit of human ampk. Variants of the α subunit of AMP-activated kinase (AMPK... |
|
|
Invention
|
Transgenic mouse expressing prkag3. Transgenic non-human animals that express the γ3 subunit of P... |
|
|
Invention
|
Prkag3 gene promoter and uses thereof.
The invention provides an isolated human Prkag3 promoter.... |
|
|
Invention
|
Prkag3 gene promoter and uses thereof. The invention provides an isolated human Prkag3 promoter&p... |
|
|
Invention
|
Variants of the alpha 1 subunit of human ampk. Variants of the &agr; subunit of AMPK, nucleic aci... |
|
|
Invention
|
Transgenic animals expressing prkag3. Transgenic nonᇁhuman animals that express the $g࿈g&r... |
|
|
Invention
|
Detection of mutations. The present invention relates to a polypeptide which is a flavin-containi... |
|
2002
|
Invention
|
Triple polypeptide complexes. The invention provides methods and materials related to treating an... |
|
|
Invention
|
Crystals and structure of synagis fab. The present invention provides machine readable media embe... |
|
|
Invention
|
Genetic research system |
|
|
Invention
|
Genetic research systems. The invention relates to systems having flexible genetic information st... |
|
2001
|
Invention
|
System and method of storing genetic information. The invention is directed to a system that prov... |
|
|
Invention
|
Combination therapy of respiratory diseases using antibodies and anti-inflammatory agents. Therap... |
|
|
Invention
|
Variants of the human amp-activated protein kinase gamma 3 subunit. PRKAG3 nucleotide and amino a... |
|
1999
|
Invention
|
Congenic animal models of non-insulin dependent diabetes mellitus. Congenic animals and animal po... |
|
1997
|
G/S
|
[ humanized monoclonal antibody against respiratory syncytial virus for scientific research use ]... |
|
1995
|
Invention
|
Transgenic non-human mammals producing bssl variants. Furthermore the invention relates to such t... |
|
|
Invention
|
Transgenic non-human mammals that express human bssl/cel. The present invention relates to a DNA ... |
|
1993
|
Invention
|
Genomic dna sequences encoding human bssl/cel. The present invention relates to a DNA molecule co... |
